Skip to main content
PMC home page
Japanese Journal of Cancer Research : Gann logoLink to Japanese Journal of Cancer Research : Gann
. 2001 Feb;92(2):231–238. doi: 10.1111/j.1349-7006.2001.tb01086.x

Pharmacodynamic Modeling of the Entire Time Course of Leukopenia after a 3‐Hour Infusion of Paclitaxel

Hironobu Minami 1,✉, Yasutsuna Sasaki 1, Torn Watanabe 2, Makoto Ogawa 3
PMCID: PMC5926694  PMID: 11223553

Abstract

The entire time course of leukopenia after anticancer treatment is clinically more relevant than a singly measured nadir count. In order to identify factors associated with neutropenic fever, a mechanistic pharmacodynamic model with two compartments corresponding to leukocytes in bone marrow and peripheral blood was applied to describe the time course of leukopenia. Seventeen patients with breast cancer were treated with 210 mg/m2 of paclitaxel infused over 3 h as a single agent in a phase II study. Adequate fitting of the time course of leukopenia was achieved in all patients, and time‐dependent parameters, including the tune period during which leukocyte counts remained below 2000/μl and the area between the curve for time versus leukocyte counts and the line of a leukocyte count of 2000/μl (A <2000), were calculated in each patient. Leukopenia was not significantly correlated with pharmacokinetic parameters, including time above a threshold concentration or the area under the tune‐concentration curve. A negative correlation between age and the sensitivity parameter of the pharmacodynamic model was observed (r2=0.21, P=0.07). Patients who experienced neutropenic fever had a larger A<2000 than patients who did not experience fever (4512 vs. 6 days/μl, P=0.05), but fever was not significantly related to any pharmacokinetic parameter or the leukocyte nadir count. Febrile episodes were better associated with the time course of leukopenia than the singly measured nadir count, and the pharmacodynamic model presents a novel platform to analyze the entire tune course of leukopenia.

Keywords: Pharmacokinetics, Pharmacodynamics, Leukopenia, Fever, Chemotherapy

Full Text

The Full Text of this article is available as a PDF (112.8 KB).

References

  • 1.Ratain , M. J. , Schilsky , R. L. , Conley , B. A . and Egorin , M. J . Pharmacodynamics in cancer therapy . J. Clin. Oncol. , 8 , 1739 – 1753 ( 1990. ). [DOI] [PubMed] [Google Scholar]
  • 2.Extra , J.‐M. , Rousseau , F. , Bruno , R. , Clavel , M. , Bail , N. L . and Marty , M . Phase I and pharmacokinetic study of taxotere (RP 56976; NSC 628503) given as a short intravenous infusion . Cancer Res. , 53 , 1037 – 1042 ( 1993. ). [PubMed] [Google Scholar]
  • 3.Mick , R . and Ratain , M. J . Modeling interpatient pharma‐codynamic variability of toposide . J. Natl. Cancer Inst. , 83 , 1560 – 1564 ( 1991. ). [DOI] [PubMed] [Google Scholar]
  • 4.Minami , H. , Ando , Y. , Sakai , S . and Shimokata , K . Clinical and pharmacologic analysis of hyperfractionated daily oral etoposide . J. Clin. Oncol. , 13 , 191 – 199 ( 1995. ). [DOI] [PubMed] [Google Scholar]
  • 5.Bodey , G. P. , Buckley , M. , Sathe , Y. S . and Freireich , E. J . Quantitative relationships between circulating leukocytes and infection in patients with acute leukemiaAnn. Intern. Med. , 64 , 328 – 340 ( 1966. ). [DOI] [PubMed] [Google Scholar]
  • 6.Rowinsky , E. K. , Grochow , L. B. , Ettinger , D. S. , Sartorius , S. R , Lubejko , B. G. , Chen , T.‐L. , Rock , M. K . and Donehower , R. C . Phase I and pharmacological study of the novel topoisomerase I inhibitor 7‐ethyl‐10‐[4‐(l‐piperidino)‐l‐piperidino]carbonyloxycamptothecin (CPT‐11) administered as a ninety‐minute infusion every 3 weeks . Cancer Res. , 54 , 427 – 436 ( 1994. ). [PubMed] [Google Scholar]
  • 7.Gianni , L. , Kearns , C. M. , Giani , A. , Capri , G. , Vign , L. , Locatelli , A. , Bonadonna , G . and Egorin , M. J . Nonlinear pharmacokinetics and metabolism of paclitaxel and its phar‐macokinetic/pharmacodynamic relationships in humans . J. Clin. OncoL , 13 , 180 – 190 ( 1995. ). [DOI] [PubMed] [Google Scholar]
  • 8.Huizing , M. T. , Keung , A. C. F. , Rosing , H. , van der Kuij , V. , ten Bokkel Huinink , W. W. , Mandjes , I. M. , Dubbelman , A. R. C. , Pinedo , H. M . and Beijnen , J. H . Pharmacokinetics of paclitaxel and metabolites in a randomized comparative study in platinum‐pretreated ovarian cancer patients . J. Clin. Oncol , 11 , 2127 – 2135 ( 1993. ). [DOI] [PubMed] [Google Scholar]
  • 9.Minami , H. , Shimokata , K. , Saka , H. , Saito , H. , Ando , Y. , Senda , K. , Nomura , F . and Sakai , S . Phase I clinical and pharmacokinetic study of a 14‐day infusion of etoposide in patients with lung cancer . J. Clin. OncoL , 11 , 1602 – 1608 ( 1993. ). [DOI] [PubMed] [Google Scholar]
  • 10.Ohtsu , T. , Sasaki , Y. , Tamura , T. , Miyata , Y. , Nakanomyo , H. , Nishiwaki , Y . and Saijo , N . Clinical pharmacokinetics and pharmacodynamics of paclitaxel: a 3‐hour infusion versus a 24‐hour infusion . Clin. Cancer Res. , 1 , 599 – 606 ( 1995. ). [PubMed] [Google Scholar]
  • 11.Karlsson , M. O. , Port , R. E. , Ratain , M. J . and Sheiner , L. B . A population model for the leukopenic effect of etoposide . Clin. Pharmacol. Ther. , 57 , 325 – 334 ( 1995. ). [DOI] [PubMed] [Google Scholar]
  • 12.Karlsson , M. O. , Molnar , V. , Bergh , J. , Freijs , A . and Larsson , R . A general model for time‐dissociated pharmacokinetic‐pharmacodynamic relationships exemplified by paclitaxel myelosuppression . Clin. Pharmacol. Ther. , 63 , 11 – 25 ( 1998. ). [DOI] [PubMed] [Google Scholar]
  • 13.Rosner , G. L . and Müller , P . Pharmacodynamic analysis of hematologic profiles . J. Pharmacokinet. Biopharm. , 22 , 499 – 524 ( 1994. ). [DOI] [PubMed] [Google Scholar]
  • 14.Kahn , M. G. , Pagan , L. M . and Sheiner , L. B . Combining physiologic models and symbolic methods to interpret time‐varying patient data . Methods Inf. Med. , 30 , 167 – 178 ( 1991. ). [PubMed] [Google Scholar]
  • 15.Minami , H. , Sasaki , Y. , Saijo , N. , Ohtsu , T. , Fujii , H. , Igarashi , T . and Itoh , K . Indirect‐response model for the time course of leukopenia with anticancer drugs . Clin. Pharmacol. Ther. , 64 , 511 – 521 ( 1998. ). [DOI] [PubMed] [Google Scholar]
  • 16.Itoh , Y. , Horikoshi , N. , Watanabe , T. , Sasaki , Y. , Tominaga , T. , Okawa , T. , Tabei , T. , Kuraishi , Y. , Tamura , K. , Abe , R. , Kitajima , M. , Yamaguchi , S. , Kobayashi , T. , Koyama , H. , Orita , K. , Takashima , S. , Nomura , Y . and Ogawa , M . Phase II study of paclitaxel (BMS‐181339) intravenously infused over 3 hours for advanced or meta‐static breast cancer in Japan . Invest. New Drug , 16 , 183 – 190 ( 1998. ). [DOI] [PubMed] [Google Scholar]
  • 17.Kearns , C. M. , Gianni , L . and Egorin , M. J . Paclitaxel pharmacokinetics and pharmacodynamics . Semin. OncoL , 22 , 16 – 23 ( 1995. ). [PubMed] [Google Scholar]
  • 18.Jusko , W. J . and Ko , H. C . Physiologic indirect response models characterize diverse types of pharmacodynamic effects . Clin. Pharmacol. Ther. , 56 , 406 – 419 ( 1994. ). [DOI] [PubMed] [Google Scholar]
  • 19.Rothstein , G . Hematopoietic cellular production . In “ Clinical Hematology ,” 9 Ed. , Vol. 1 , ed. Lee G. R. , Bithell T. C. , Foerster J. , Athens J. W. and Lukens J. N. , pp . 48 – 54 ( 1993. ). Lea & Febiger; , Philadelphia . [Google Scholar]
  • 20.Boll , I . and Kühn , A . Granulocyotopoiesis in human bone marrow cultures studied by means of kinematography . Blood , 26 , 449 – 470 ( 1965. ). [PubMed] [Google Scholar]
  • 21.Mauer , A. M. , Athens , J. W. , Aschenbruchker , H . and Cartwright , G. E . Leukokinetic studies. U. A method for labeling granulocytes in vitro with radioactive diisopropyl‐fluorophosphate (DFP32) . J. Clin. Invest. , 39 , 1481 – 1486 ( 1960. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Fliedner , T. M. , Cronkite , E. P. , Killmann , S. A . and Bond , V. P . Granulocytopoiesis. II. Emergence and pattern of labeling of neutrophilic granulocytes in humans . Blood , 24 , 683 – 700 ( 1964. ). [PubMed] [Google Scholar]
  • 23.Cartwright , G. E. , Athens , J. W . and Wintrobe , M. M . The kinetics of granulopoiesis in normal man . Blood , 24 , 780 – 803 ( 1964. ). [PubMed] [Google Scholar]
  • 24.Athens , J. W . Neutrophil kinetics and function . In “ Clinical Hematology ” 9 Ed. , Vol. 1 , ed. Lee G. R. , Bithell T. C. , Foerster J. , Athens J. W. and Lukens J. N. , pp . 239 – 247 ( 1993. ). Lea & Febiger; , Philadelphia . [Google Scholar]
  • 25.Lee , M. A. , Segal , G. M . and Babgy , G. C . The hematopoi‐etic microenvironment in the elderly: defects in IL‐1‐induced CSF expression in vitro . Exp. Hematol. , 17 , 952 – 956 ( 1989. ). [PubMed] [Google Scholar]
  • 26.Rothstein , G. , Christensen , R. D . and Nielsen , B. R . Kinetic evaluation of the pool sizes and proliferative response of neutrophils in bacterially challenged aging mice . Blood , 70 , 1836 – 1841 ( 1987. ). [PubMed] [Google Scholar]
  • 27.Timaffy , M . A comparative study of bone marrow function in young and old individuals . Geront. Clin. , Basel , 13 – 18 ( 1962. ). [DOI] [PubMed] [Google Scholar]
  • 28.Selig , C . and Nothdurft , W . Cytokines and progenitor cells of granulocytopoiesis in peripheral blood of patients with bacterial infections . Infect. Immunol. , 63 , 104 – 109 ( 1995. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29.Stewart , C . Protein binding; assessment and importance . In “ A Clinician's Guide to Chemotherapy: Pharmacokinetics and Pharmacodynamics ,” ed. Grochow L. B. and Ames M. M. , pp . 55 – 66 ( 1998. ). Williams and Wilkins; , Baltimore . [Google Scholar]
  • 30.Bruno , R. , Hille , D. , Riva , A. , Vivier , N. , ten Bokkel Huin‐nink , W. W. , van Oosterom , A. T. , Kaye , S. B. , Verweij , J. , Fossella , F. V. , Valero , V. , Rigas , J. R. , Seidman , A. D. , Chevallier , B. , Fumoleau , P. , Burris , H. A. , Ravdin , P. M . and Sheiner , L. B . Population pharmacokinetics/phar‐macodynamics of docetaxel in phase II studies in patients with cancer . J. Clin. Oncol , 16 , 187 – 196 ( 1998. ). [DOI] [PubMed] [Google Scholar]

Articles from Japanese Journal of Cancer Research : Gann are provided here courtesy of Wiley

RESOURCES